UPMC

Running trials

• Recruiting

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· Phase 3· Source

• Recruiting

  A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT07581184· Phase 1· Source

• Active, not recruiting

  Use of Wearables Following Cystectomy- Part II

  NCT07148765· Source

• Recruiting

  A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

  NCT07020117· Phase 1· Source

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· Phase 2· Source

• Recruiting

  Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

  NCT06029491· Source

• Recruiting

  Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction

  NCT06831149· Phase 2· Source

• Recruiting

  A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  NCT06774963· Phase 1· Source

• Recruiting

  Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  NCT06456593· Phase 2· Source

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Source

• Recruiting

  VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

  NCT06264180· Phase 3· Source

• Active, not recruiting

  A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06132893· Phase 2/3· Source

• Recruiting

  PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  NCT05934487· Source

• Active, not recruiting

  PA Moves Trial - Patient Participants

  NCT05227105· Source

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Source

• Active, not recruiting

  Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

  NCT05384587· Phase 2· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Source

• Active, not recruiting

  PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

  NCT04089059· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer2 recruiting
• Lung cancer2 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• Epilepsy1 recruiting
• Heart failure1 recruiting
• Melanoma1 recruiting
• Ovarian cancer1 recruiting
• Prostate cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

  NCT06939036· Phase 1/2· Source

• Recruiting

  A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  NCT06586957· Phase 1· Source

• Completed

  Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

  NCT06089135· Source

• Completed

  Health Outcomes of Parents With Cystic Fibrosis

  NCT05829694· Source

• Completed

  Hydroxyurea and EPO in Sickle Cell Disease

  NCT05451940· Phase 1/2· Source

• Completed

  PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

  NCT04925492· Phase 1· Source

• Completed

  RNS System NAUTILUS Study

  NCT05147571· Source

• Completed

  A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

  NCT05018650· Source

• Completed

  Letermovir for CMV Prevention After Lung Transplantation

  NCT05041426· Phase 2· Source

• Completed

  The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

  NCT04129125· Source

• Completed

  Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

  NCT04343209· Source

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Source

• Completed

  Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

  NCT04121676· Phase 1· Source